Ares Management Corporation ARES
136.23 USD +7.29 (+5.66%)
Nov 4, 2026, 2:47 PM EST
132.49 Day range 137.79
96.50 52-week range 178.28
- YTD
- -15.72%
- 1 year
- -10.97%
Analyst view
Consensus: buy
Buy
Price target (mean) 146.50 +7.5% upside
Now 136.23
- Target (low)
- 128.00
- Target (mean)
- 146.50
- Target (high)
- 171.00
Ratings (0m) 20 13 buy · 7 hold · 0 sell
- Strong buy5
- Buy8
- Hold7
- Sell0
- Strong sell0
Recommendation trend
- This month 20
- 1 month ago 20
- 2 months ago 19
- 3 months ago 18
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.82 | 1.75 – 1.97 | 1.45 | +25.5% | 1.42B | +14.1% | 15 |
| Next quarter | 1.45 | 1.25 – 1.53 | 1.24 | +16.7% | 1.28B | +17.1% | 12 |
| Current year | 5.64 | 5.54 – 5.86 | 4.76 | +18.5% | 4.92B | +15.5% | 17 |
| Next year | 6.98 | 6.55 – 7.29 | 5.64 | +23.7% | 5.82B | +18.3% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 30, 2026 | Keefe, Bruyette & Woods | Maintained | Market Perform | Market Perform |
| Oct 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 27, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 19, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 12, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 2, 2026 | Wells Fargo | Initiated | — | Overweight |
| Sep 24, 2026 | Piper Sandler | Initiated | — | Overweight |
| Aug 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 3, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 3, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 3, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 3, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 3, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jul 17, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 13, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jul 9, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 9, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 23, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 18, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 4, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 4, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 28, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 22, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Apr 21, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 13, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
